Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Selective nAChR ligands prepared by Novo Nordisk

Feb. 27, 1997

Sano begins pivotal trials with smoking cessation product

Feb. 26, 1997

Allelix and Pharm-Eco form joint venture

Jan. 27, 1997

NIH seeks licensees for dopamine reuptake inhibitors

Jan. 23, 1997

Altus receives grant for nerve agent neutralization

Jan. 21, 1997

Innovative NRT recommended for approval

Dec. 19, 1996

Advisory committee recommends approval of non-nicotine smoking cessation product

Dec. 13, 1996

NDA filed for Antizol

Dec. 13, 1996

New use claimed for olanzapine

Nov. 26, 1996

LecTec cleared to proceed with clinical testing of smoking cessation product

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 22, 2025.
Makary’s vision for slimmed-down US FDA somewhat reassuring
BioWorld
Nearly three weeks into the job, U.S. FDA Commissioner Marty Makary provided a comprehensive overview of his vision for the much-reduced agency, even as he’s...
Dupixent bounces back in treating hives with FDA approval
BioWorld
The U.S. FDA issued a complete response letter in October 2023 for Dupixent (dupilumab) in treating chronic hives but has now approved the monoclonal antibody for...
Akeso scores China approval for ebdarokimab in plaque psoriasis
BioWorld
China’s National Medical Products Administration has given the thumbs up to Akeso Pharmaceuticals Inc.’s ebdarokimab for treating moderate to severe plaque...